Study: Treating Psychosis with Anti-Inflammatories Possible
Wednesday, March 6, 2013
A new genetic study has provided backing for the theory that inflammation in the brain is a cause of psychosis. Researchers in Sweden have discovered that a genetic variant that boosts the effects of inflammation in the brain is more common in people with bipolar disorder who experience psychotic episodes.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.